GlobalData on MSN1d
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
Mucus in nose and throat: How to stop post-nasal drip at home
Post-nasal drip occurs when excess mucus accumulates in the back of the throat or nose, primarily due to allergies, ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Rolling Out5d
The truth about this common cold remedy
The FDA reveals that phenylephrine, a popular decongestant, is no better than a placebo. Discover what this means for your ...
Keymed Biosciences Inc.: Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...
Rolling Out1d
The surprising side effect Ozempic users never expected
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
BMJ6d
Medical news in brief: Sickle cell treatment, prostate cancer, patient complaints, and other stories
Sarah Benn loses suspension appeal The retired GP and climate activist Sarah Benn lost her High Court appeal against a misconduct finding and suspension by a medical practitioners’ tribunal over her ...
emjreviews.com5d
NICE Endorses First-of-Its-Kind Allergic Rhinitis Treatment
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
pulmonologyadvisor22h
Nasal Spray Formulation of Bumetanide Under FDA Review
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Over 89,000 Bottles of Nasal Spray Recalled By FDA—What to Know
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...